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Abstract Areca nut chewing habits are associated
with several oral manifestations like leukoplakia,
submucous fibrosis and oral squamous cell carcinoma.
Although numerous evidence on areca toxicity is
known but the mechanistic pathway of disease causa-
tion is to be studied. Aqueous areca nut extract treated
A549 cells showed reduced cell viability by 48 h with
IC50 value of 0.50%. The toxic nature of areca nut
induced the production of reactive oxygen species
with decreased anti-oxidant glutathione S transferase
levels lead to altered redox homeostasis. PCR studies
showed decreased mRNA levels of Jun and Fos AP-1
subunits on extract treatment by 48 h. The protein
levels of PCNA, CDK4, RB, p53, c-Jun and c-Fos
were found to be downregulated with upregulated
CDK inhibitor p21 on extract treatment as compared
to control. Results of FACS analysis further confirm
G1/S phase cell cycle arrest on areca nut extract
exposure. The regulation of downstream AP-1
subunits by MAPKs was studied by using specific
inhibitors of ERK, JNK and p38 along with areca nut
extract. Results showed the redox activation of MAP
kinases down regulated the mRNA levels of AP-1
subunits in aqueous areca nut extract treated cells.
Hence the present study aids in elucidating the role of
MAP kinases in regulating the AP-1 subunits and their
implications on target genes that are involved regula-
tion of various cellular processes. Further, it would
help in understanding the mechanistic aspects of the
diseased state which may facilitate in designing of new
therapeutic modalities that could help in cancer
management.
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Introduction
The International Agency for Research on Cancer
(IARC) has classified betel quid with or without
tobacco as group I human carcinogens that are closely
associated with an elevated risk of orally potential
malignant disorders (OPMDs) and cancers of the oral
cavity. Worldwide there are around 600 million betel
quid chewers (Chen et al. 2018). The concurrent use of
areca nut has increased the occurrence of oral cancer
in some Western Pacific island countries and is
associated with significant morbidity and mortality
rates. Globally, mortality rate from oral cancer, is less
than 50% based on a 5 yr. mortality rate, however,
mortality rates was as high as 67 to 80% have been
reported from some countries in the Western Pacific
Region (World Health Organization 2012). Studies
have shown the cytotoxic and genotoxic effect of areca
nut extract on cultured human oral epithelial cells
(Sundqvist et al. 1989). Increased production of
reactive oxygen species (ROS) in several types of
cells were observed on areca nut exposure (Chang
et al. 2001; Liu et al. 1996). Excessively produced free
radical further depletes anti-oxidants and thereby
generates oxidative stress and leads to alteration in
bio-chemical processes like cell growth, gene expres-
sion, and apoptosis. Further increased ROS mediates
various signaling cascade relating to survival, prolif-
eration, resistance to apoptosis, angiogenesis and
metastases in pre-cancerous cells as well as cancer
cells, which may promote cancer initiation and
progression (Halliwell 2007).
Among which redox activation of certain transcrip-
tion factors like Activator Protein-1(AP-1), Nuclear
factor Kappa B (NF-jB) through mitogen activated
protein kinases (MAPKs) and its components like
extracellular regulated kinase (ERK), Jun N terminal
kinase (JNK) and p38 which play important role in
maintaining various biological processes. AP-1 is the
first dimeric mammalian transcription factor to be
identified (Angel and Karin 1991) which includes a
menagerie of basic leucine zipper (bZIP) proteins that
belong to the Jun, Fos, Maf and ATF sub-families
(Chinenov and Kerppola 2001). These factors are
activated in response to an incredible array of stimuli,
including mitogenic growth factors, inflammatory
cytokines, UV and ionizing irradiation, cellular stress,
and neoplastic transformation (Angel and Karin
1991). The diverse combinational dimers of AP-1
subunits are known to regulate several biological or
pathological status of an organism, which participates
in various signaling pathways stimulated by great
variety of extracellular signals (Wisdom 1999).
Although there exists numerous evidence on the
biological significance and physiological functions
of AP-1 and its components but it’s still being
explicated. Previous studies states that AP-1 activity
with that of growth factors and tumor promoters
prompts the relatedness of regulatory act in cellular
growth control and neoplastic transformation (Hsu
et al. 1993). Despite of increasing awareness about the
physiological functions of AP-1 but their function of
target genes are not always obvious (Shaulian and
Karin 2002). There are evidences that AP-1 proteins,
mostly those that belong to the Jun group, control cell
survival and death through their ability to regulate the
expression and function of cell cycle regulators such
as Cyclin D1, p53, p21cip1/waf1, p19ARF and p16
(Shaulian and Karin 2001, 2002). Amongst the Jun
proteins, c-Jun is unique in its ability to positively
regulate cell proliferation through the repression of
tumor suppressor gene expression and induction of
cyclin D1. c-Jun actions are antagonized by Jun B,
which upregulates tumor suppressor genes and
represses cyclin D1. The tumor suppressor p53, an
important target of AP-1 are known to regulate their
effects on cell survival and death, whose expression as
well as transcriptional activity is modulated by AP-1
proteins (Shaulian et al. 2000).
Analysis of in vitro cell culture models that exhibit
altered expression of individual AP-1 members
revealed unique and crucial roles for each Jun
proteins, but some functional redundancy appears
among the Fos proteins. Inhibition of Fos and Jun
expression in mouse fibroblasts and erythroleukaemia
cells using antisense RNA demonstrated their require-
ment in proliferation and cell cycle progression
(Shaulian and Karin 2001). Similarly, microinjection
of antibodies against Fos and Jun prevents serum
stimulated quiescent mouse fibroblasts from re-enter-
ing the cell cycle (Kovary and Bravo 1991). Interest-
ingly, non-cross reactive antibodies against any Jun
protein, including Jun B, inhibit cell cycle entry,
whereas simultaneous inactivation of several Fos
proteins is required to achieve a similar effect (Kovary
and Bravo 1991), suggesting a unique and critical role
for each AP-1 protein. Hence in the present study
human lung A549 cells were used has an in vitro
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model system to study the effect of aqueous areca nut
extract on viability, on redox homeostasis and their
influence on activation of mitogen activated protein
kinases in regulation of downstream AP-1 transcrip-
tion factors and their influence on target genes which
further decides the cellular fate.
Materials and Methods
A549 cells (human lung adenocarcinoma cancer cells)
were purchased from NCCS (Pune, India); TRIzol,
and Oligo’s forward and reverse primers for AP-1
factors (Table 1) were purchased from Sigma-Aldrich
(St. Louis, USA). Fetal bovine serum (FBS), peni-
cillin, streptomycin, glutamine, RPMI 1640 medium,
3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), dimethyl sulfoxide (DMSO), dichlo-
rofluorescein diacetate (DCFDA), 1-Chloro-2,4-dini-
trobenzene (CDNB),Tris base, Sodium Chloride,
Glycine, Ammonium per sulphate, tween 20, sodium
dodecyl sulphate, acrylamide, bis acrylamide, sodium
acetate were purchased from Himedia (Mumbai,
India). Oligo dTs and superscript reverse transcriptase
were obtained from Invitrogen Bio Services India Pvt.
Ltd. (Bangalore, India). Taq DNA polymerase, BrdU
ELISA Kit and anti-rabbit/mouse secondary antibody
HRP conjugate was purchased from Merck-Millipore
(Mumbai, India). Antibodies to PCNA, RB, CDK4,
p21, p53, c-Jun, and c-Fos were purchased from Neo
Biolabs (MA, USA).
Culturing of A549 cells
A549 cells were grown in 25 cm2 culture flask using
RPMI-1640 media with 10% FBS, 100 U/ml peni-
cillin and 100 lg/ml streptomycin and 2 mM L-glu-
tamine. Cells were cultured in a humidified
atmosphere at 37 C by supplying 5% CO2 in an
incubator. The 80–90% confluent flask containing
cells were trypsinised and sub cultured to 96 or 6 well
plates for further treatments (Kiran Kumar et al. 2016).
Preparation of aqueous extract of areca nut
Areca nut was collected from Uttara Kannada district,
Karnataka, India. Areca nut was finely powered using
pestle and mortar, 1 g of powdered areca nut was
suspended in 10 ml of sterile water to prepare 10%
stock (w/v) and placed in orbitary shaker at room
temperature for 24 h and the extract was filtered using
Whatmann no. 1 filter paper. The main stock (10%)
was further diluted with media (e.g. 0.1 ml of areca
nut main stock in 9.90 ml media gives 0.1% (v/v)
concentration) to treat cells with different concentra-
tions or stored at - 20 C until further use (Nagesh
et al. 2016).
Table 1 Sequence of primers (F: forward and R: reverse) used for the amplification of different AP-1 factors
Gene Primer sequence Annealing temp. (C) Product size. (bp) PCR cycles
AP-1 factors
c-Jun F: GCCTACAGATGAACTCTTTCTGGC
R: CCTGAAACATCGCACTATCCTTTG
64 525 30
Jun-D F: CGCAGCCTCAAACCCTGCCTTTCC
R: AAACAGGAATGTGGACTCGTAG
64 500 30
Jun-B F: CCAGTCCTTCCACCTCGACGTTTACAAG
R: GACTAAGTGCGTGTTTCTTTTCCACAGTAC
58 257 30
c-Fos F: TCTTCCTTCGTCTTCACC
R: AATCAGAACACACTATTGCC
58 577 30
Fra-1 F: AGGAAGGAACTGACCGAC
R: GAAGGGGAGGAGACATTG
60 497 30
b-actin F: TACCACTGGCATCGTGATGGACT
R: TCCTTCTGCATCCTGTCGGCAAT
62 516 30
F forward, R reverse
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Cell viability assay (MTT)
The viable cell percentage was measured by MTT
assay as described earlier (Mosmann 1983). A549
cells were seeded at density of 3 9 103 cells/well in a
96-well plate and incubated overnight in a CO2
incubator. Cells were then exposed to fresh media
containing different concentration of aqueous areca
nut extract (0.1, 0.25, 0.5, 0.75 and 1.0%) for 48 h.
After the incubation period, 50 ll (2 mg/ml) of MTT
was added into each well and incubated for 4 h,
insoluble formazan formed by viable cells were finally
dissolved in DMSO (100 ll) and read against blank
using a microplate reader (Perkin Elmer) at 540 nm.
Reactive oxygen species (ROS) assay
ROS generated in cells by the action of toxic
substances were measured as per the protocol
described earlier (Periyakaruppan et al. 2009). A549
cells (3 9 103 cells/well) were cultured overnight in a
black colored 96-well plate, washed with phosphate
buffered saline (PBS) and treated with 10 lMDCFDA
in 1 N NaOH for 3 h. Further, the cells were washed
with PBS and incubated with different concentration
of aqueous extract of areca nut in media for 15 min.
The fluorescent intensity was recorded using a mul-
timode plate reader (Perkin Elmer) at excitation
wavelength of 485 nm and emission of 527 nm.
Glutathione S-transferase (GST) assay
GST assay was carried out as per the protocol
described earlier (Mannervik 1985). A549 cells
(5 9 105 cells/well) were cultured in a 6-well plate
and incubated overnight. Cells were treated with or
without different concentration of aqueous extract of
areca nut and further incubated for 24 h. Cell lysate
was prepared using 200 ll lysis buffer/well. 100 ll
cell lysate was added to 900 ll enzyme cocktail
containing PBS of pH 6.5, 100 mM CDNB in ethanol
and 100 mM reduced glutathione in water. Reaction
mixture was incubated at room temperature for 5 min
and absorbance was measured spectrophotometrically
at 340 nm.
Cell cycle analysis by flow cytometry using
propidium iodide staining
A549 cells were cultured in a 6 well plate and treated
with or without different concentration of areca nut
extract (0.25 and 0.5%) for 24 h. The cells residing at
different phases of cell cycle in treated samples were
measured by flow cytometric analysis as per the man-
ufacturers protocol. After incubation the cells were
harvested, fixed in ethanol and stained with propidium
iodide (50 lg/ml) and the cells residing in different
phases were analyzed using a FACS Scan laser flow
cytometric analysis system (Scientific Instruments
Centre, Indian Institute of Science, Bengaluru). The
percentage of cells residing in different phases of cell
cycle was compared with control.
RNA isolation and semi-quantitative RT-PCR
analysis
A549 cells (5 9 105 cells/well) were seeded into
6-well plate and incubated with or without aqueous
areca nut extract (0.25 and 0.5%) for 48 h. Total RNA
was isolated from control and treated cell samples
using TRIzol reagent as per the manufacturer instruc-
tions. Reverse transcription of RNA and PCR analysis
were carried out as per the protocol described earlier
(Sharma et al. 1999). Total RNA (2 lg) from different
samples were reverse-transcribed using Oligo (dT)
primers and superscript reverse transcriptase. The
cDNA was subjected to 30 cycles of PCR in a gradient
Eppendorf thermo cycler using different forward and
reverse primers of AP-1 factors (Table 1). The b-actin
was used as a positive control and for normalization.
Amplified PCR products were analyzed by elec-
trophoresis using 1% agarose gels and 1X TAE buffer.
Western blotting
The total cell protein extracts of A549 cells from
control and aqueous areca nut extract treated samples
were prepared and specific protein levels were
analyzed by Western blotting as per the protocol
described earlier (Sharma et al. 1999). The control and
treated cells present in 6-well plate were washed thrice
with PBS and 0.2 ml of ice cold cell lysis buffer was
added. Cells were scraped and suspension was gently
transferred to a pre-cooled Eppendorf tube, mixed
gently by swirling on ice and centrifuged at
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15,0009g for 20 min at 4 C. Supernatant was used to
determine protein concentration by Bradford’s method
(Bradford 1976). The cell lysates containing equal
amount of protein (60 lg) of different samples were
separated on SDS–polyacrylamide gel electrophoresis
(SDS-PAGE) and electrophoretically transferred on to
PVDF membrane. The membrane was blocked with
5% Carnation fat-free milk at room temperature for
1 h. Primary Antibody (PCNA or CDK4 or RB or p53
or p21 or c-Jun or c-Fos) in blocking solution (1:1000)
was added and incubated for overnight, washed and
incubated with anti-rabbit/mouse secondary antibody-
HRP (1:500), and further incubated for 1 h at room
temperature. Immunoreactive proteins were visual-
ized using Luminata Forte Western HRP substrate as
per the specifications provided by the supplier in
Syngene Gel Documentation system (MD, USA).
Immunoreactive bands were quantified using image
analysis software (Image J). GAPDH was used as a
positive control and for normalization.
Statistical analysis
Experimental data shown as mean ± standard devia-
tion from three independent experiments. Statistical
analysis for MTT, ROS and GST assays was carried
out by Student’s t test, mRNA and protein analysis was
done by one-way ANOVA followed by post hoc tukey
test. Difference between control and aqueous areca nut
treated cell samples were considered significant if the
level was *P\ 0.05, **P\ 0.01 and ***P\ 0.001
and #P\ 0.05 when compared to aqueous areca nut
extract treated samples.
Results
Aqueous areca nut extract reduces the viability
of A549 cells
A549 cells were treated with or without different
concentration of aqueous areca nut extract for 48 h
and the viability were determined by MTT assay.
Results show that the aqueous areca nut extract
decreased cell viability in a dose dependent manner
by 48 h. More than 50% decrease in viability was
found at 0.5% aqueous areca nut extract in A549 cells
as compared to control (Fig. 1).
Aqueous extract of areca nut induces reactive
oxygen species (ROS) in A549 cells
A549 cells were treated with or without different
concentration of aqueous areca nut extract and total
ROS produced in cells were measured. Results show
that aqueous areca nut extract induced ROS in a dose
dependent manner. More than 60% increase in
production of ROS at 1% aqueous areca nut extract
treated cells was observed as compared to control
(Fig. 2).
Fig. 1 Effect of aqueous extract of areca nut on the viability of
A549 cells. Values were expressed as mean ± SD (n = 4).
Results were significantly different from control if *P\ 0.05;
**P\ 0.01 and ***P\ 0.001 by using student’s t-test
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Fig. 2 Effect of aqueous extract of areca nut on ROS
production in A549 cells. Values were expressed as mean ± SD
(n = 4). Results are significantly different from control if
*P\ 0.05; **P\ 0.01 and ***P\ 0.001 by using student’s
t-test
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Areca nut extract decreases glutathione
S-transferase activity in A549 cells
A549 cells were treated with or without different
concentration of aqueous areca nut extract for 24 h
and GST enzyme activity were assayed. Results show
that the cells treated with aqueous areca nut extract
decreased the GST enzyme activity in a dose depen-
dent manner. Cells treated with 1% aqueous areca nut
extract showed 15% decrease in GST enzyme activity
as compared to control (Fig. 3).
Areca nut extract induces G1/S phase cell cycle
arrest
Cells treated with different concentration of aqueous
extract of areca nut (0.25 and 0.5%) for 24 h and the
cells were harvested and fixed in chilled ethanol.
Further fixed cells were subjected to propidium iodide
stain for 15–20 min and were analyzed for the cells
residing in different phase of the cell cycle. Results of
flow cytometric analysis showed cells on treatment
with 0.25% extract showed 65.7% cells residing at G1
phase further with increased areca nut concentration
i.e., 0.5% showed 72.9% cells residing at G1 phase of
cell cycle. Further, the treated cells showed decrease
in the cell number that entered S phase by 10.5% with
0.25 and 4.4% with 0.5% concentrations of aqueous
areca nut extract as compared to control cells (Fig. 4).
Flow cytometric analysis suggest induction of G1/S
phase cell cycle arrest in aqueous areca nut extract
treated A549 cells.
Areca nut extract induces p21 and inhibits p53,
CDK4, RB and PCNA protein levels in A549 cells
Cells treated with or without different concentration of
aqueous areca nut extract showed dose dependent
decrease in protein levels of major cell cycle regula-
tors. Areca nut extract treated A549 cells showed
decreased protein levels of PCNA by 36 and 68%,
CDK4 by 39 and 61%, RB by 59 and 75% and p53 by
51 and 61% with 0.25 and 0.50% areca nut extract
respectively as compared to control. Whereas CDK
inhibitor p21 showed increased protein level by
twofold with 0.50% areca nut extract (Fig. 5).
Down regulation of AP-1 (Jun and Fos) transcripts
in areca nut extract treated A549 cells
A549 cells showed the mRNAs expression of Jun (c-
Jun, Jun B, and Jun D) and Fos (Fra-1, Fra-2, and
c-Fos) family members at different levels. A549 cells
treated with aqueous areca nut extract decreases the
expression of Jun and Fos family members of AP-1
factors in dose dependent manner when compared to
control. There was a significant decrease in mRNA
expression of c-Jun by 18 and 20%, Jun B by 31 and
59% and Jun D by 10 and 14%, similarly Fos family
member also show significant decrease in expression
of c-Fos by 65 and 83%, Fra-1 by 34 and 62% and Fra-
2 by 9 and 71% with 0.25 and 0.5% areca nut extract
respectively when compared to control (Fig. 6). The
results suggested that the Jun and Fos family members
are probably involved in down regulation of major cell
cycle regulator in areca nut extract treated cells leads
to decrease in the cell viability.
Aqueous areca nut extract down regulates
the protein levels of AP-1 factors (c-Jun and c-Fos)
A549 cells treated with or without different concen-
tration (0.25 and 0.5%) of areca nut extract showed
decrease in protein levels of c-Jun and c-Fos in a dose
dependent manner. Results shows decrease in c-Jun
protein levels by 59 and 61% and c-Fos by 37 and 53%
in cells treated with 0.25 and 0.5% areca nut extract
respectively when compared to control (Fig. 7).
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Fig. 3 Effect of aqueous extract of areca nut on GST activity in
A549 cells. Values were expressed as mean ± SD (n = 3).
Results are significantly different from control if *P\ 0.05;
**P\ 0.01 and ***P\ 0.001 by using student’s t-test. Units:
lM of CDNB conjugated/min/mg protein
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ERK inhibitor U0126 decreased the mRNA levels
of AP-1 factors in areca nut extract treated cells
To study the role of ERK MAPK pathway on
downstream expression pattern of AP-1 subunits in
areca nut extract treated cells. A549 cells were
pretreated with or without U0126 for 1 h before
treating it with or without areca nut extract. Cells
treated with areca nut extract showed decreased
expression of c Jun by 52%, Jun B by 13%, Jun D
was non-significant, c Fos by 14%, Fra 1 by 37% and
Fra 2 by 37%with 0.5% areca nut extract treated A549
cells respectively when compared to control. Whereas
cells treated in combination with U0126 and areca nut
extract showed decrease in mRNA levels of c Jun by
18%, Jun B by 25%, Jun D by non-significant, c Fos by
52%, Fra 1 by 09% and Fra 2 by 48% with 10 lM
U0126 along with 0.5% areca nut extract treated A549
cells respectively when compared to areca nut extract
treated cells (Fig. 8).
JNK inhibitor SP600125 downregulated the mRNA
levels of Jun AP-1 factors in areca nut extract treated
cells
To study the role of JNK MAPK pathway on
downstream expression pattern of AP-1 subunits in
areca nut extract treated cells. A549 cells were
Fig. 4 Effect of areca nut extract on induction of cell cycle arrest in A549 cells. Results were expressed as % of cells residing in
different phase of cell cycle such as Sub G0, G1/S and G2/M as compared to control
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Fig. 5 Effect of areca nut extract on protein levels of cell cycle
regulators in A549 cells. Data shown are mean ± SD (n = 3)
and differences in protein levels of cell cycle regulators are
statistically significant: if *P\ 0.05 compared with control
using one-way ANOVA followed by post hoc Tukey test. The
bar graphs represent the respective densitometric analysis
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pretreated with or without SP600125 for 1 h before
treating it with or without areca nut extract. Cells
treated with arecoline showed decreased expression of
c Jun by 38%, Jun B 33%, Jun D 38%, c Fos by 54%,
Fra 1 by 18% and Fra 2 by non-significant with 0.5%
areca nut extract treated A549 cells respectively when
compared to control. Whereas cells treated in combi-
nation with SP600125 and areca nut extract showed
decrease in mRNA levels of c Jun by 17%, Jun B by
37%, Jun D by non-significant, c Fos by 13%, Fra 1 by
09% and Fra 2 by non-significant with 10 lM
SP600125 along with 0.5% areca nut extract treated
A549 cells respectively when compared to alone areca
nut extract treated cells (Fig. 9).
p38 inhibitor SB202190 decreased mRNA levels
of AP-1 subunits in areca nut extract treated cells
To study the role of p38 MAPK pathway on down-
stream expression pattern of AP-1 subunits in areca
nut extract treated cells with. A549 cells were
pretreated with or without SB202190 for 1 h before
treating it with or without areca nut extract. Cells
treated with areca nut extract showed decreased
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Fig. 6 Effect of areca nut extract on the mRNAs expression of
AP-1 factors in A549 cells. Data shown are mean ± SD (n = 3)
and differences in mRNA levels of AP-1 factors are statistically
significant, if *P\ 0.05 compared with control, as analyzed
using one-way ANOVA followed by post hoc Tukey test. The
bar graph represents their respective densitometric analysis
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Fig. 7 Effect of areca nut extract on protein levels of AP-1
factors in A549 cells. Data shown are mean ± SD (n = 3) and
differences in protein levels of AP-1 factors are statistically
significant: if *P\ 0.05 compared with control using one-way
ANOVA followed by post hoc Tukey test. The bar graph
represents their respective densitometric analysis
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expression of c Jun by 54%, Jun B by 15%, Jun D 18%,
c Fos by 74%, Fra 1 by 61% and Fra 2 by non-
significant with 0.5% areca nut extract treated A549
cells respectively when compared to control. Whereas
cells treated in combination with SB202190 and areca
nut extract showed decrease in mRNA levels of c Jun
by 17%, Jun B by non-significant, Jun D by 21%, c Fos
by 17%, Fra 1 by 20% and Fra 2 by 29% with 10 lM
SB202190 along with 0.5% areca nut extract treated
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Fig. 8 Effect of U0126 on the mRNA transcripts of AP-1
factors in areca nut extract treated cells. Data shown are
mean ± SD (n = 3) and differences in mRNA levels of AP-1
factors are statistically significant: if *P\ 0.05 compared with
control and #P\ 0.05 as compared to areca nut extract values
using one-way ANOVA followed by post hoc Tukey test. The
bar graph represents their respective densitometric analysis
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Fig. 9 Effect of SP600125 on mRNA transcripts of AP-1
factors in arecanut extract treated cells. Data shown are
mean ± SD (n = 3) and differences in mRNA levels of AP-1
factors are statistically significant: if *P\ 0.05 compared with
control and #P\ 0.05 as compared to areca nut extract values
using one-way ANOVA followed by post hoc Tukey test. The
bar graph represents their respective densitometric analysis
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A549 cells respectively when compared to alone areca
nut extract treated cells (Fig. 10).
Discussion
Although there exist abundant evidence that show
strong correlation between betel quid chewing and the
incidence of oral cancer, leukoplakia and oral submu-
cous fibrosis (OSF) (Canniff et al. 1986; IARC 1985).
Areca nut and its component arecoline have long been
reflected to be the key etiologic factors in the
pathogenesis of oral cancer and OSF (Canniff et al.
1986; Jeng et al. 2001). Arecoline, an alkaloid of areca
nut also demonstrates genotoxic effects in both
bacterial test systems as well as cultured mammalian
cells (IARC 1985; Jeng et al. 2001). However, the
effects of areca nut extract on cellular toxicity,
oxidative stress, cell cycle regulation and the down-
stream activation and regulation of AP-1 transcription
factors through MAP kinases and their controlling
mechanism in deciding the cellular fate will be
discussed below. MTT assay showed decreased via-
bility of A549 cells by 48 h on areca nut extract
treatment these are in agreement with previous reports,
where areca nut extract and arecoline were found to be
cytotoxic and genotoxic to various kinds of cells
thereby inhibited the growth of oral mucosal fibrob-
lasts and gingival fibroblasts (Jeng et al. 1999, 2001).
Further extract treated cells showed increasing DCF
fluorescence as an indication of induced ROS in a dose
dependent manner followed by decreased enzyme
activity of glutathione S transferase. Previous studies
(Chang et al. 2001; Lu et al. 2010) have shown
excessively produced ROS brings about morpholog-
ical changes on areca nut extract treatment. Recently,
production of ROS (Clutton 1997; Shackelford et al.
1999) and depletion of cellular glutathione (Schnell-
dorfer et al. 2000; Vahrmeijer et al. 1999) have been
shown to influence on cell cycle progression, apopto-
sis and chemical toxicity.
Deregulation of cell cycle control is one of the
major causes of cancer induction (Laird and Shal-
loway 1997). Impairment of cell cycle by toxic
chemicals usually leads to growth retardation, cyto-
toxicity and apoptosis (Li and Brooks 1999; Smith and
Fornace 1996). Therefore, it is of interest to know
whether areca nut extract affects cell cycle progres-
sion. Cyclins dependent kinases and cyclins are the
regulators players which controls the progression on
cell cycle. Cyclin D1 along with CDK4/6 kinases
initiate the phosphorylation of the RB (retinoblas-
toma) and this complex is inhibited by p16 as well as
p21 inhibitor which plays a key role in cell cycle arrest
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Fig. 10 Effect of SB202190 on the mRNA transcripts of AP-1
factors in extract treated cells. Data shown are mean ± SD
(n = 3) and differences in mRNA levels of AP-1 factors are
statistically significant: if *P\ 0.05 compared with control and
#P\ 0.05 as compared to areca nut extract values using one-
way ANOVA followed by post hoc Tukey test. The bar graph
represents the densitometric analysis
123
516 Cytotechnology (2019) 71:507–520
at the G1 checkpoint in response to DNA damage.
Areca nut extract treated A549 cells showed decreased
protein levels of PCNA (proliferative cell nuclear
antigen), CDK4, RB and p53 with increased p21
levels. Similar results were observed in normal human
oral keratinocytes with increased p16 and p21 levels
(Lu et al. 2006) along with decreased mRNA levels of
Cyclin E1, Cyclin D1, CDK4, RB, p53 and upregu-
lated p16 and p21 levels in human A549 cells on areca
nut extract exposure (Nagesh et al. 2016). Corre-
spondingly, Lee et al. (2005) showed increased levels
of PCNA in lesions of oral lichen planus in areca quid
chewing patients. The upregulated p21 can be a major
element underlying G1 phase cell cycle arrest which is
further confirmed by FACS analysis. Similar results
were observed in oral carcinoma 3 cells on areca nut
extract exposure for 24 h showed G1/S phase cell
cycle arrest (Lu et al. 2010). Active tumor suppressor
p53 are known to protect cells from DNA damages by
inducing its target genes. The molecules activated by
p53 induce apoptosis, cell cycle arrest and DNA repair
to conserve the genome (Blagosklonny and Pardee
2002). However, the activation of p53 will be reflected
by the amount of protein or the phosphorylation level
of Ser-15, but it was not in the case of areca nut extract
treatment. Thus it would state that the damage caused
by areca extract may bypass the surveillances of p53
and undergo genetic pathogenesis prompting tumori-
genesis and suggested that the activation of p21 by
areca nut is p53-independent (Lu et al. 2006). Results
of the study put forward that CDK inhibitor (p21/p16)
act as negative regulators in modulating cell arrest on
areca-mediated cellular toxicity. The regular impair-
ments of such regulatory genes in areca nut associated
oral squamous cell carcinoma might substantiate the
fact that keratinocyte lacking such genomic protection
may confer tumorigenic propensity (Chang et al. 2000;
Lin et al. 2000). Further Chang et al. (2001) also
observed deregulated cell cycle arrest with areca nut
and arecoline exposure which would lead to numerous
oral carcinogenesis. The mechanism behind the up-
regulation of p21 is not well understood. It is
hypothesized that ROS elicited by areca nut extract
could be an important trigger (Liu et al. 1996). Induced
production of ROS facilitates error prone DNA
replication with increased expression of CDK inhi-
bitor p21 and further leads to G1/S phase cell cycle
arrest in arecoline treated which may contribute to
OSCC (Ji et al. 2012). The modification of gene
expression by ROS has direct effects on cell prolifer-
ation and apoptosis through the activation of MAPKs
and its regulation of transcription factors like AP-1
and NF-jB (Waris and Ahsan 2006). Studies on
genetically modified mice and cells have highlighted a
crucial role for AP-1 in a variety of cellular events
involved in normal development or neoplastic trans-
formation causing cancer. However, emerging evi-
dence indicates that the contribution of AP-1 for
determination of cellular fates critically depends on
the relative abundance of AP-1 subunits, the compo-
sition of AP-1 dimers, the quality of stimulus, the cell
type and the cellular environment. Therefore, AP-1-
mediated regulation of various cellular processes
should be considered within the context of a complex
dynamic network of signaling pathways and other
nuclear factors that respond simultaneously.
The signaling cascades elicited by ROS culminates
the activation of AP-1 factors, c-Jun and c-Fos
subunits involved in regulation of cellular prolifera-
tion. Results of the study showed decreased mRNA
expression of both Jun and Fos family members of AP-
1 on areca nut extract exposure. Similarly, protein
levels of c-Jun and c-Fos were found to be down
regulated followed by areca nut extract treatment.
Studies have shown that ROS triggered transcription
factor showed inhibition of thioredoxins which in turn
inhibits several pro-survival transcription factors such
as Egr-1, AP-1 and NF-jB resulting in a G1 phase
arrest (Cook et al. 2004). AP-1 proteins control cell
cycle progression by regulating the expression of key
components of the cell cycle machinery. Normally
c-Jun stimulates G1 to S phase transition by repressing
p53, which in turn reduces p21 levels which later
induces cyclin D1and CDK4 complex. c-Fos and Fos
B have redundant functions in the stimulation of S
phase entry and the induction of cyclin D1 expression.
Jun B inhibits G1 to S phase transition by inducing p16
and repressing cyclin D1. Jun D inhibits S phase entry
and increases the numbers of resting cells by modu-
lating the Ras/p53 pathway (Jochum et al. 2001;
Mechta et al. 1997; Shaulian et al. 2000). Further,
reduced expression of c-Jun on areca nut treatment
may be one such factor responsible for decreased
Cyclin D1 levels. Due to the toxic effect of areca nut,
the levels of Jun subunit have come down along with
down regulated cyclins and CDKs which would aid in
transition of cells from G1 to S phase of cell cycle with
induction of p21 an inhibitor of CDKs. (Passegue and
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Wagner 2000). Further, studies were carried to
confirm the involvement of MAPKs in regulation of
downstream AP-1 transcription factors by using
specific inhibitors of ERK (U0126), JNK
(SP600125) and p38 (SB202190) along with areca
nut extract. Results showed decreased mRNA expres-
sion on both Jun and Fos family members on
pretreatment of ERK inhibitor with areca extract,
while JNK inhibitor with extract showed significant
decrease in mRNA levels of Jun family members of
AP-1 whereas p38 inhibitor with areca extract showed
decrease mRNA levels of most of the AP-1 players.
These results are in agreement with studies carried by
(Tseng et al. 2007), on normal oral keratinocytes have
shown the activation of p38 MAP kinases and a low or
transient activation of JNK by areca nut was observed
in SAS cells (Lu et al. 2010). Similarly areca
ingredients activated MEK pathway which in turn
regulate the downstream transcription factors that are
involved in modulating various pathophysiological
processes (Chang et al. 2004). Thus, results of the
study show the active involvement of stress active
JNK and p38 MAPKs regulate the expression of
downstream AP-1 transcription factors. Therefore, the
present study aids in better understanding the role
MAPKs in regulation of AP-1 transcription factors and
their influence on major cell cycle regulators which in
turn helps in deciding the cellular fate in areca nut
extract treated human lung cancer A549 cells. This
would further help in designing new therapeutic
approach to suppress the oncogenic act of specific
AP-1 subunits, which would facilitate to provide a
better treatment strategy for cancer management.
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